The overactive bladder: Epidemiology and morbidity.

The overactive bladder: Epidemiology and morbidity.

Item
http://www.wikidata.org/entity/Q36608339
Trospium chloride treatment of overactive bladderLoss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndromeThe surgical management of the refractory overactive bladder.Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus.A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder.Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option.Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women?Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation.Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials.
P2860

The overactive bladder: Epidemiology and morbidity.

Item
http://www.wikidata.org/entity/Q36608339
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The overactive bladder: Epidemiology and morbidity.
@ast
The overactive bladder: Epidemiology and morbidity.
@en
type
label
The overactive bladder: Epidemiology and morbidity.
@ast
The overactive bladder: Epidemiology and morbidity.
@en
prefLabel
The overactive bladder: Epidemiology and morbidity.
@ast
The overactive bladder: Epidemiology and morbidity.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
The overactive bladder: Epidemiology and morbidity.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698